May. 23. 2025Topics
The Kashiwanoha Regenerative Medicine Platform Website is now open!
ーWhat is the Kashiwanoha Regenerative Medicine Platform?
This platform is being developed by the stakeholders (National Cancer Center, Teijin/J-TEC, Mitsui Fudosan) in the area surrounding Kashiwanoha Smart City (Kashiwa City, Chiba Prefecture), which aims to become a new hub for life sciences in Japan. Teijin and J-TEC, a Teijin group company that develops regenerative medicine products, have established CDMO base in Mitsui Link Lab Kashiwa-no-ha 1. We are working together to leverage our respective strengths and enhance synergies.
